A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy Patients

NCT01224028 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

IgA Nephropathy

Interventions

DRUG: Tacrolimus
DRUG: Placebo

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]